• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素诱导仓鼠运动活动的抑制:时间依赖性及中枢型苯二氮䓬拮抗剂Ro 15 - 1788的抑制作用

Melatonin-induced depression of locomotor activity in hamsters: time-dependency and inhibition by the central-type benzodiazepine antagonist Ro 15-1788.

作者信息

Golombek D A, Escolar E, Cardinali D P

机构信息

Departamento de Fisiología, Facultad de Medicina, Universidad de Buenos Aires, Argentina.

出版信息

Physiol Behav. 1991 Jun;49(6):1091-7. doi: 10.1016/0031-9384(91)90336-m.

DOI:10.1016/0031-9384(91)90336-m
PMID:1654569
Abstract

The aim of the present study was to determine whether melatonin-induced depression of locomotor activity in hamsters is time-dependent and to analyze the inhibitory effects of the central-type benzodiazepine (BZP) antagonist Ro 15-1788 on melatonin-induced depression of locomotor behavior. Activity was monitored and registered by means of an optical actometer. Two phases of locomotor behavior were found. The initial phase, found both at noon and during the evening, exhibited an absence of diurnal variability, while a second long-lasting phase of activity exhibited a peak at early night. The IP injection of melatonin (minimal effective dose: 100 micrograms/kg) inhibited the early phase of activity at 1200 or 2000 h. Inhibition of the late phase of activity was found at 2000 or 0400 h, but not at midnight. When assessed at 2000 h, melatonin depression of the early phase of locomotor activity attained significance after 5 days of injection, while its effect on the late phase of activity attained significance during the second day of injection. The administration of Ro 15-1788, although unable by itself to modify locomotor activity, significantly attenuated the inhibitory effects of melatonin. These results indicate the existence of a time-dependency for melatonin activity on locomotor behavior similar to that known to occur for other effects of the hormone, and further support a link between melatonin and the activity of central type BZP receptors.

摘要

本研究的目的是确定褪黑素诱导仓鼠运动活动降低是否具有时间依赖性,并分析中枢型苯二氮䓬(BZP)拮抗剂Ro 15-1788对褪黑素诱导的运动行为降低的抑制作用。通过光学活动计监测并记录活动情况。发现运动行为有两个阶段。在中午和晚上都能观察到的初始阶段,不存在昼夜变化,而第二个持续时间较长的活动阶段在深夜达到峰值。腹腔注射褪黑素(最小有效剂量:100微克/千克)可在1200或2000时抑制活动的早期阶段。在2000或0400时可发现对活动后期的抑制作用,但在午夜未观察到。在2000时进行评估时,注射5天后,褪黑素对运动活动早期阶段的抑制作用达到显著水平,而其对活动后期阶段的作用在注射第二天达到显著水平。Ro 15-1788的给药虽然本身不能改变运动活动,但能显著减弱褪黑素的抑制作用。这些结果表明,褪黑素对运动行为的活性存在时间依赖性,类似于该激素其他作用所已知的情况,并进一步支持了褪黑素与中枢型BZP受体活性之间的联系。

相似文献

1
Melatonin-induced depression of locomotor activity in hamsters: time-dependency and inhibition by the central-type benzodiazepine antagonist Ro 15-1788.褪黑素诱导仓鼠运动活动的抑制:时间依赖性及中枢型苯二氮䓬拮抗剂Ro 15 - 1788的抑制作用
Physiol Behav. 1991 Jun;49(6):1091-7. doi: 10.1016/0031-9384(91)90336-m.
2
Chronopharmacology of melatonin: inhibition by benzodiazepine antagonism.褪黑素的时辰药理学:苯二氮䓬拮抗作用的抑制
Chronobiol Int. 1992 Apr;9(2):124-31. doi: 10.3109/07420529209064523.
3
Melatonin accelerates reentrainment after phase advance of the light-dark cycle in Syrian hamsters: antagonism by flumazenil.
Chronobiol Int. 1993 Dec;10(6):435-41. doi: 10.1080/07420529309059719.
4
Time-dependent melatonin analgesia in mice: inhibition by opiate or benzodiazepine antagonism.小鼠中褪黑素的时间依赖性镇痛作用:阿片类或苯二氮䓬类拮抗剂的抑制作用
Eur J Pharmacol. 1991 Feb 26;194(1):25-30. doi: 10.1016/0014-2999(91)90119-b.
5
Time-dependent anticonvulsant activity of melatonin in hamsters.
Eur J Pharmacol. 1992 Jan 21;210(3):253-8. doi: 10.1016/0014-2999(92)90412-w.
6
A benzodiazepine antagonist, Ro 15-1788, can block the phase-shifting effects of triazolam on the mammalian circadian clock.一种苯二氮䓬拮抗剂Ro 15 - 1788能够阻断三唑仑对哺乳动物生物钟的相位转移效应。
Brain Res. 1988 Mar 22;444(2):333-9. doi: 10.1016/0006-8993(88)90942-0.
7
Melatonin as an anxiolytic in rats: time dependence and interaction with the central GABAergic system.
Eur J Pharmacol. 1993 Jun 24;237(2-3):231-6. doi: 10.1016/0014-2999(93)90273-k.
8
Midazolam, a short-acting benzodiazepine, resets the circadian clock of the hamster.咪达唑仑是一种短效苯二氮䓬类药物,可重置仓鼠的生物钟。
Pharmacol Biochem Behav. 1989 Apr;32(4):901-6. doi: 10.1016/0091-3057(89)90056-7.
9
Melatonin administered in the afternoon decreases next-day luteinizing hormone levels in men: lack of antagonism by flumazenil.下午服用褪黑素可降低男性次日的促黄体生成素水平:氟马西尼无拮抗作用。
J Mol Neurosci. 1999 Feb;12(1):75-80. doi: 10.1385/JMN:12:1:75.
10
Circadian phase-shifts induced by chlordiazepoxide without increased locomotor activity.氯氮卓诱导的昼夜节律相移,且运动活性未增加。
Brain Res. 1993 Sep 17;622(1-2):58-62. doi: 10.1016/0006-8993(93)90801-s.

引用本文的文献

1
Melatonin's Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights.褪黑素作为治疗老年人睡眠障碍的疗法的益处与风险:当前见解
Nat Sci Sleep. 2022 Oct 14;14:1843-1855. doi: 10.2147/NSS.S380465. eCollection 2022.
2
Exogenous daytime melatonin modulates response of adolescent mice in a repeated unpredictable stress paradigm.外源性日间褪黑素在重复不可预测应激范式中调节青春期小鼠的反应。
Naunyn Schmiedebergs Arch Pharmacol. 2017 Feb;390(2):149-161. doi: 10.1007/s00210-016-1314-7. Epub 2016 Nov 14.
3
Central depressant and nootropic effects of daytime melatonin in mice.
白天褪黑素对小鼠的中枢抑制和益智作用。
Ann Neurosci. 2014 Jul;21(3):90-6. doi: 10.5214/ans.0972.7531.210304.
4
Neuroprotection by radical avoidance: search for suitable agents.通过自由基避免实现神经保护:寻找合适的药物。
Molecules. 2009 Dec 7;14(12):5054-102. doi: 10.3390/molecules14125054.
5
Decrease in spontaneous motor activity and in brain lipid peroxidation in manganese and melatonin treated mice.锰和褪黑素处理的小鼠自发运动活动及脑脂质过氧化作用降低。
Neurochem Res. 1999 May;24(5):705-8. doi: 10.1023/a:1021064711866.
6
The rhythmic GABAergic system.节律性γ-氨基丁酸能系统。
Neurochem Res. 1998 May;23(5):607-14. doi: 10.1023/a:1022426519297.
7
Sedative potency and 2-[125I]iodomelatonin binding affinity of melatonin analogues.褪黑素类似物的镇静效力及2-[¹²⁵I]碘褪黑素结合亲和力
Psychopharmacology (Berl). 1995 Feb;117(3):364-70. doi: 10.1007/BF02246111.